Table 1.
Stress/Disease | Expression (protein, mRNA or immunoreactive) | ||
---|---|---|---|
TSP1 | CD47 | SIRP-α | |
Stress: | |||
Hypoxia | Increased | Increased | NK |
TSP1 | NK | NK | Increased activity |
Enalaparil | Increased | NK | NK |
Ferric nitrilotriacetate | NK | Increased | NK |
Mercuric chloride | Increased | NK | NK |
LPS | NK | Increased | NK |
Thy1.1 Ab | Increased | Increased | Decreased activity |
Immune-associated | Increased in multiple diseases | NK | NK |
Infection | NK | Decreased | NK |
Metabolic (Diabetes) | Increased | Decreased | NK |
eNOS deletion (low vascular NO) | Increased | NK | NK |
Ureteral ligation | Increased | NK | NK |
Non-renal transplant-related IRI: | |||
Orthotopic liver transplant | Increased | NK | NK |
Increased | Increased | Increased | |
Renal vascular occlusion | |||
Transplant-related IRI | Increased | NK | NK |
NK – Not Known